循環器ジャーナル67巻4号

2019年10月発行

特集 冠動脈疾患のリスク管理のフロントライン Ⅲ．冠動脈疾患合併症をどう管理する？

弁膜症をどう防ぎ治療する？

著者： 岩崎陽一¹ 冨山博史¹

所属機関： ¹東京医科大学病院循環器内科

ページ範囲：P.662 - P.669

Point
・高齢化に伴い心不全患者数が増加しており，弁膜症に対する適切な治療方法が求められている．
・弁膜症治療の第一選択肢は外科的治療だが，近年ハイリスク症例に対しては非侵襲的治療が可能になっている．

参考文献

1) Okura Y, Ramadan MM, Ohno Y, et al:Impending epidemic:future projection of heart failure in Japan to the year 2055. Circ J 72:489-491, 2008

2) 日本循環器学会：弁膜疾患の非薬物治療に関するガイドライン（2012年改訂版）．2012

3) Rahimtoola SH, Durairaj A, Mehra A, et al:Current evaluation and management of patients with mitral stenosis. Circulation 106:1183-1188, 2002

4) Vahanian AS:Valvuloplasty. In, Topol EJ, ed:Textbook of Cardiovascular Medicine. pp.2155-2175, Lippincott-Raven Pblishers, Philadelphia, 1998

5) Borer JS, Hochreiter CA, Supino PG, et al:Importance of right ventricular performance measurement in selecting asymptomatic patients with mitral regurgitation for valve surgery. Adv Cardiol 39:144-152, 2002

6) Grossi EA, Goldberg JD, LaPietra A, et al:Ischemic mitral valve reconstruction and replacement:comparison of long-term survival and complications. J Thorac Cardiovasc Surg 122:1107-1124, 2001

7) Capomolla S, Febo O, Gnemmi M, et al:Beta-blockade therapy in chronic heart failure:diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 139:596-608, 2000

8) Comin-Colet J, Sánchez-Corral MA, Manito N, et al:Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction. Transplant Proc 34:177-178, 2002

9) Levine AB, Muller C, Levine TB. Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. Am J Cardiol 82:1299-1301, 1998

10) Waagstein F, Strömblad O, Andersson B, et al:Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure:a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy. Eur J Heart Fail 5:679-691, 2003

11) Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875-883, 2005

12) Gillinov AM, Faber C, Houghtaling PL, et al:Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg 125:1350-1362, 2003

13) Nagendran J, Norris C, Maitland A, et al:Is mitral valve surgery safe in octogenarians? Eur J Cardiothorac Surg 28:83-87, 2005

14) Stone GW, Lindenfeld J, Abraham WT, et al:Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 379:2307-2318, 2018

15) Obadia JF, Messika-Zeitoun D, Leurent G, et al:Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. The New England journal of medicine. N Engl J Med 379:2297-2306, 2018

16) Lincoln J, Garg V:Etiology of valvular heart disease-genetic and developmental origins. Circ J 78:1801-1807.2014

17) Dewey TM, Brown DL, Herbert MA, et al:Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 89:758-767, 2010

18) Moat NE, Ludman P, de Belder MA, et al:Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis:the U.K. TAVI（United Kingdom Transcatheter Aortic Valve Implantation）Registry. J Am Coll Cardiol 58:2130-2138, 2011

19) Goel SS, Agarwal S, Tuzcu EM, et al:Percutaneous coronary intervention in patients with severe aortic stenosis:implications for transcatheter aortic valve replacement. Circulation 125:1005-1013, 2012

20) Mack MJ, Leon MB, Thourani VH, et al:Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 380:1695-1705, 2019

21) Mahajerin A, Gurm HS, Tsai TT, et al:Vasodilator therapy in patients with aortic insufficiency:a systematic review. Am Heart J 153:454-461, 2007

22) Yang LT, Michelena HI, Scott CG, et al:Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines. J Am Coll Cardiol 73:1741-1752, 2019